» Articles » PMID: 23533585

ß-Adrenergic Stimulation Increases RyR2 Activity Via Intracellular Ca2+ and Mg2+ Regulation

Overview
Journal PLoS One
Date 2013 Mar 28
PMID 23533585
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Here we investigate how ß-adrenergic stimulation of the heart alters regulation of ryanodine receptors (RyRs) by intracellular Ca(2+) and Mg(2+) and the role of these changes in SR Ca(2+) release. RyRs were isolated from rat hearts, perfused in a Langendorff apparatus for 5 min and subject to 1 min perfusion with 1 µM isoproterenol or without (control) and snap frozen in liquid N2 to capture their phosphorylation state. Western Blots show that RyR2 phosphorylation was increased by isoproterenol, confirming that RyR2 were subject to normal ß-adrenergic signaling. Under basal conditions, S2808 and S2814 had phosphorylation levels of 69% and 15%, respectively. These levels were increased to 83% and 60%, respectively, after 60 s of ß-adrenergic stimulation consistent with other reports that ß-adrenergic stimulation of the heart can phosphorylate RyRs at specific residues including S2808 and S2814 causing an increase in RyR activity. At cytoplasmic [Ca(2+)] <1 µM, ß-adrenergic stimulation increased luminal Ca(2+) activation of single RyR channels, decreased luminal Mg(2+) inhibition and decreased inhibition of RyRs by mM cytoplasmic Mg(2+). At cytoplasmic [Ca(2+)] >1 µM, ß-adrenergic stimulation only decreased cytoplasmic Mg(2+) and Ca(2+) inhibition of RyRs. The Ka and maximum levels of cytoplasmic Ca(2+) activation site were not affected by ß-adrenergic stimulation. Our RyR2 gating model was fitted to the single channel data. It predicted that in diastole, ß-adrenergic stimulation is mediated by 1) increasing the activating potency of Ca(2+) binding to the luminal Ca(2+) site and decreasing its affinity for luminal Mg(2+) and 2) decreasing affinity of the low-affinity Ca(2+)/Mg(2+) cytoplasmic inhibition site. However in systole, ß-adrenergic stimulation is mediated mainly by the latter.

Citing Articles

Roles of β-adrenoceptor Subtypes and Therapeutics in Human Cardiovascular Disease: Heart Failure, Tachyarrhythmias and Other Cardiovascular Disorders.

Wong Y, Haqqani H, Molenaar P Handb Exp Pharmacol. 2024; 285:247-295.

PMID: 38844580 DOI: 10.1007/164_2024_720.


Phosphorylation of phospholamban promotes SERCA2a activation by dwarf open reading frame (DWORF).

Bovo E, Jamrozik T, Kahn D, Karkut P, Robia S, Zima A Cell Calcium. 2024; 121:102910.

PMID: 38823350 PMC: 11247691. DOI: 10.1016/j.ceca.2024.102910.


Hypermagnesemia in Clinical Practice.

Aal-Hamad A, Al-Alawi A, Kashoub M, Falhammar H Medicina (Kaunas). 2023; 59(7).

PMID: 37512002 PMC: 10384947. DOI: 10.3390/medicina59071190.


The prognostic impact of magnesium in acute heart failure is different according to the presence of diabetes mellitus.

Cidade-Rodrigues C, Cunha F, Elias C, Carreira M, Barroso I, Bettencourt P Porto Biomed J. 2023; 7(6):e197.

PMID: 37152077 PMC: 10158881. DOI: 10.1097/j.pbj.0000000000000197.


Targeting p21-activated kinase 1 for development of a novel anti-arrhythmic drug class.

He Y, Grassam-Rowe A, Lei M, Bae J Philos Trans R Soc Lond B Biol Sci. 2023; 378(1879):20220285.

PMID: 37122206 PMC: 10150222. DOI: 10.1098/rstb.2022.0285.


References
1.
Reiken S, Gaburjakova M, Guatimosim S, Gomez A, DArmiento J, Burkhoff D . Protein kinase A phosphorylation of the cardiac calcium release channel (ryanodine receptor) in normal and failing hearts. Role of phosphatases and response to isoproterenol. J Biol Chem. 2002; 278(1):444-53. DOI: 10.1074/jbc.M207028200. View

2.
Dulhunty A, Laver D, Curtis S, Pace S, Haarmann C, Gallant E . Characteristics of irreversible ATP activation suggest that native skeletal ryanodine receptors can be phosphorylated via an endogenous CaMKII. Biophys J. 2001; 81(6):3240-52. PMC: 1301783. DOI: 10.1016/S0006-3495(01)75959-0. View

3.
Xiao B, Tian X, Xie W, Jones P, Cai S, Wang X . Functional consequence of protein kinase A-dependent phosphorylation of the cardiac ryanodine receptor: sensitization of store overload-induced Ca2+ release. J Biol Chem. 2007; 282(41):30256-64. DOI: 10.1074/jbc.M703510200. View

4.
Laver D . Luminal Ca(2+) activation of cardiac ryanodine receptors by luminal and cytoplasmic domains. Eur Biophys J. 2009; 39(1):19-26. DOI: 10.1007/s00249-009-0417-1. View

5.
Ullrich N, Valdivia H, Niggli E . PKA phosphorylation of cardiac ryanodine receptor modulates SR luminal Ca2+ sensitivity. J Mol Cell Cardiol. 2012; 53(1):33-42. PMC: 3674825. DOI: 10.1016/j.yjmcc.2012.03.015. View